Examination Report |
1 | Note Sheet | 11 Feb 2009 |
10 | Correspondence | 11 Oct 2012 |
11 | TM-5 | 09 Nov 2012 |
12 | TM-5 | 10 Dec 2012 |
13 | Cover To Cover | 04 May 2019 |
14 | Journal Copy | 30 Mar 2022 |
15 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 28 Apr 2022 |
16 | Order | 05 Jul 2023 |
17 | Evidence Affidavit Under Rule 46 (TOP) | 08 Nov 2023 |
18 | Annexure -1 under rule 46 | 08 Nov 2023 |
19 | Letter of Relying | 27 Dec 2023 |
2 | Examination Report | 11 Feb 2009 |
2 | Power of Attorney | 11 Feb 2009 |
3 | Additional Representation Sheet | 11 Feb 2009 |
4 | Examination Report | 11 Feb 2009 |
4 | Power of Attorney | 11 Feb 2009 |
5 | Other Documents | 16 Feb 2009 |
5 | TM-1 | 16 Feb 2009 |
6 | Other Documents | 16 Feb 2009 |
6 | TM-1 | 16 Feb 2009 |
7 | Reply to Exam Report (MIS-R) | 03 Apr 2012 |
8 | Authorization Letter | 16 Aug 2012 |
8 | Order | 16 Aug 2012 |
9 | Authorization Letter | 16 Aug 2012 |
9 | Order | 16 Aug 2012 |
1 | Opposition Notice | 13267738 | 5560975 | 30 Mar 2022 |
2 | Opposition Counter Statement | 14628823 | 5825555 | 12 Jan 2023 |
3 | Hearing Notice | 14628839 | 5825585 | 12 Jan 2023 |
4 | Hearing Notice | 15032984 | 5908929 | 29 Mar 2023 |
5 | Hearing Notice | 15461843 | 6015492 | 20 Jun 2023 |
6 | Report Rule 45(2) Opposition | 15550545 | 6037948 | 05 Jul 2023 |
The application for Dex orofer was made on 11 February 2009.
The trademark applicant for Dex orofer is EMCURE PHARMACEUTICALS.
Dex orofer is applied in class(es) 5.
Application for Dex orofer is on Opposed stage.
Application Id allotted to Dex orofer is 1784196.
Trademark agent or attorney for the application is Aditya & Associates.
Dex orofer filed with the Intellectual property office as a WORD.